Answers are grounded in this paper and cite their sources.
Novel gold(I)-BODIPY-imidazole complexes show anti-inflammatory and anticancer potential, suggesting therapeutic advancements.
Two new gold(i)-BODIPY-imidazole based trackable therapeutic bimetallic complexes have been synthesized and fully characterized. They display strong antiproliferative properties on several types of cancers including colon, breast, and prostate and one of them presents a significant anti-inflammatory effect. Additionally, the two compounds could be visualised in vitro by confocal microscopy in the submicromolar range.
No takes yet. Share an insight, caveat, or question.
Trommenschlager et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: